Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $23.14M.
ENTERPRISE VALUE (EV)
$23.14M
Cytosorbents Corporation
Market Cap
$12.73M
Enterprise Value (EV)
$23.14M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Cytosorbents Corporation (CTSO) | $12.73M | $23.14M |
| Lantern Pharma Inc. (LTRN)vs › | $11.83M | $5.21M |
| IRIDEX Corporation (IRIX)vs › | $12.12M | $11.45M |
| Lisata Therapeutics, Inc. (LSTA)vs › | $11.47M | $1.03M |
| Adial Pharmaceuticals, Inc. (ADIL)vs › | $11.42M | N/A |
| Bullfrog AI Holdings, Inc. Common Stock (BFRG)vs › | $11.38M | $4.56M |
| Kiora Pharmaceuticals, Inc. (KPRX)vs › | $11.23M | $4.49M |
| Biofrontera Inc. (BFRI)vs › | $11.04M | $13.89M |
| BioVie Inc. (BIVI)vs › | $11.01M | $2.31M |
| Cerenome, Inc. (CNSY)vs › | $10.91M | $8.59M |
Market Cap
$12.73M
Total Debt
$16.67M
Cash
$6.25M
Enterprise Value
$23.14M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
